Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit

Go back to Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 9.10 -0.17 (1.83%)
Previous Close $9.27    52 Week High $9.58 
Open $9.41    52 Week Low $2.34 
Day High $10.24    P/E N/A 
Day Low $8.58    EPS $-0.34 
Volume 61,279